# Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

> **NCT00001239** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 100 (—)

## Conditions studied

- Breast Cancer
- Breast Neoplasms

## Interventions

- **DRUG:** FLAC with GM-CSF

## Key facts

- **NCT ID:** NCT00001239
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-07
- **Primary completion:** —
- **Final completion:** 2001-01
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001239, "Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00001239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*